Earnings ·
Ceribell reports Q3 revenue of $29.3M, up 30%, and raises full-year guidance to $115M-$117M
CBLLCeribell, Inc.
Ceribell reported third-quarter 2026 total revenue of $29.3 million, a 30% increase from the prior year period, driven by record utilization within its existing account base and new customer additions. The company achieved a gross margin of 90% and raised its full-year 2026 revenue guidance to a range of $115 million to $117 million. Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.